Konstantinos Vlasis

Konstantinos Vlasis

Auto-generated profile, based on publicly available information

Konstantinos Vlasis

1st Cardiology Clinic, Hippokration Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2020 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Closed access
KLKonstantinos Liapis
Konstantinos Liapis
NTNikolaos Tasis
Nikolaos Tasis
ITIoannis Tsouknidas
Ioannis Tsouknidas
GTGEORGE TSAKOTOS
GEORGE TSAKOTOS
PSPanagiotis Skandalakis
Panagiotis Skandalakis
DFDIMITRIOS FILIPPOU
DIMITRIOS FILIPPOU
Uterine arteries are the main vessels supplying blood to the uterus. Mainly, they originate from the anterior trunk of the internal iliac artery. Uterine arteries play an important role in pregnancy as well as transcatheter arterial embolization for postpartum hemorrhage and uterine fibroid management. This is a review of the English literature in the PubMed database of the anatomic variety on the origin of uterine arteries and their clinical significance. Eleven studies describe the origin of the uterine arteries and their variations in the literature. In six studies, the uterine artery emerged from internal iliac artery in the majority of the cases, either as a separate branch, or as a bifurcation with the inferior gluteal artery, or trifurcation with superior and inferior gluteal artery. In two studies, the inferior gluteal artery manifested as the main source of the uterine artery, whereas in three studies, the umbilical artery posed as its main origin. Internal iliac artery is described as the most common vascular origin of uterine artery. However, this review highlights that the main vessels of origin for uterine arteries are internal iliac, umbilical and inferior gluteal artery. Nevertheless, classification and further research for this peculiar anatomic structure is fundamental in the future.

4 August 2008 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
KTKonstantinos Tsioufis
Konstantinos Tsioufis
MDMaria Drakopoulou
Maria Drakopoulou
Polychronis DilaverisPolychronis Dilaveris
Polychronis Dilaveris
SVSophia Vaina
Sophia Vaina
KGKostas Gatzoulis
Kostas Gatzoulis
CSChristodoulos Stefanadis
Christodoulos Stefanadis

8 April 2021 in Surgical Innovation
Verified
Journal Article
Closed access
PDF file
PMPanayiotis D. Megaloikonomos
Panayiotis D. Megaloikonomos
OSOlga Savvidou
Olga Savvidou
AVAsimina Vlachaki
Asimina Vlachaki
VIVasilios G. Igoumenou
Vasilios G. Igoumenou
KVKonstantinos Vlasis
Konstantinos Vlasis
PPPanayiotis J. Papagelopoulos
Panayiotis J. Papagelopoulos
Greece, one of the oldest civilizations of the world, fundamentally contributed to the establishment and evolution of medicine and surgery. Undoubtedly, the foundations of the orthopaedic science are dated back to antiquity. The journey of the orthopaedic art was inaugurated with the poems of Homer and incarcerated through the practices of Hippocrates and Galen. Their deep knowledge of the musculoskeletal conditions and their treatment was generously bequeathed to humanity. This heritage acted as the catalyst for the establishment of orthopaedics in the modern Greek era. In this article, we tried to illustrate the evolution of the orthopaedic art in Greece from antiquity to modern times, reviewing the available evidence from scientific articles, books, historical manuscripts, old newspapers, and biographies. We summarize the most important events, and we identify the pioneers that shaped this new surgical branch, creating the modern Greek orthopaedic discipline.

1 January 2021 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
VKVasileios A. Kechagias
Vasileios A. Kechagias
Theodoros GrivasTheodoros Grivas
Theodoros Grivas
PPPanayiotis J. Papagelopoulos
Panayiotis J. Papagelopoulos
VASILEIOS KONTOGEORGAKOSVASILEIOS KONTOGEORGAKOS
VASILEIOS KONTOGEORGAKOS
KVKonstantinos Vlasis
Konstantinos Vlasis
Kechagias VA, et al. Clin Orthop Surg. 2021 Mar;13:e42. https://doi.org/10.4055/cios20123

1 May 2020 in The Journal of Sports Medicine and Physical Fitness
Verified
Journal Article
Closed access
CKChristos Koutserimpas
Christos Koutserimpas
KVKonstantinos Vlasis
Konstantinos Vlasis
MMMarinos C. Makris
Marinos C. Makris
AIArgyrios Ioannidis
Argyrios Ioannidis
MKMichael K. Konstantinidis
Michael K. Konstantinidis
KKKonstantinos M. Konstantinidis
Konstantinos M. Konstantinidis
Athletic pubalgia is an obscure sport injury, presenting mainly with groin pain during twisting movements. The present 15 year study reports outcomes, intraoperative findings and complications of the endoscopic surgical treatment in competitive athletes. All competitive athletes, from 2004 to 2018, suffering from athletic pubalgia, treated with laparoscopic Total Extra-Peritoneal technique, at the Department of General, Laparoscopic, Oncologic and Robotic Surgery of the Athens Medical Center were included in this retrospective cohort. Postoperative pain, complications, return to previous training routine and patients' satisfaction were evaluated. A total of 130 patients (115; 88.5% males and 15; 11.5% females) with a mean age of 26.7±7.5 years were evaluated. Preoperatively, mean numeric scale pain was found to be 7.7±1.7. Three days postoperatively, the mean numeric pain scale was 3.4±1.5, showing 55.8% decrease. The mean time for return to sports activity was found to be 6.27±3.02 weeks. Regarding complications, six patients (4.6%) had slight numbness at the groin area during the first 6 postoperative months and one patient (0.8%) suffered from a postoperative hematoma. No recurrence was observed. At the final follow-up (mean 76.58±46.5 months), a total of 97 (74.7%) patients were very satisfied, 31 (23.8%) satisfied and two (1.5%) not satisfied with the outcome. Laparoscopic operative treatment in competitive athletes suffering from athletic pubalgia seems to offer rapid recovery, rapid return to sports, as well as very low complications rate and no recurrence.

13 August 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AKAimilios Kalampogias
Aimilios Kalampogias
GSGerasimos Siasos
Gerasimos Siasos
EVANGELOS OIKONOMOUEVANGELOS OIKONOMOU
EVANGELOS OIKONOMOU
Konstantinos MourouzisKonstantinos Mourouzis
Konstantinos Mourouzis
EBEvanthia Bletsa
Evanthia Bletsa
Dimitris TousoulisDimitris Tousoulis
Dimitris Tousoulis
Background: In recent years much research has been devoted to the deployment of biomarkers in the field of heart failure. Objectives: To study the potential of post-transcriptional regulation by microRNAs on the diagnosis, management and therapy of heart failure. Methods: Literature search focus on the role of microRNAs in heart failure. Results: MicroRNAs are expressed and regulated in the course of the pathological manifestations of heart failure (HF). This wide and uncharted area of genetic imprints consisting of small non-coding RNA molecule is upregulated and released into the bloodstream from organs under certain conditions and or stress. The use of genetically based strategies for the management of HF has gained great interest in the field of biomedical science because they can be used as biomarkers providing information regarding cardiac status and function. They also appear as promising tools with therapeutic potential because of their ability to induce changes at the cellular level without creating alterations in the gene sequence. In addition, with the advances in genomic sequencing, quantification and synthesis in technologies of microRNAs identification as well as the growing knowledge of the biology of miRNAs and their involvement in HF, it is expected to favorably affect the prognosis of HF patients. Conclusion: MicroRNAs are involved in the regulation of multibiological processes involved in the progress of heart failure. More studies are needed to achieve a clinical valuable implementation of microRNAs in the management of HF.